Yuika Sasatani

Mito, 3100015, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Long-term treatment effi cacy in a rapid growth malignant undiff erentiated lung tumor.

Long-term treatment effi cacy in a rapid growth malignant undiff erentiated lung tumor.

Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti

Published: August 05, 2025

Long‑term control in a patient with lung adenocarcinoma, nonbacterial thrombotic endocarditis and multiple systemic emboli: A case report.

Long‑term control in a patient with lung adenocarcinoma, nonbacterial thrombotic endocarditis and multiple systemic emboli: A case report.

Journal: Experimental and therapeutic medicine

Published: August 02, 2023

Eosinophilic Pneumonia with Marked Peripheral Eosinophilia during the Course of Sarcoidosis.

Eosinophilic Pneumonia with Marked Peripheral Eosinophilia during the Course of Sarcoidosis.

Journal: Maedica

Published: February 23, 2023

Five-year Disease Control With Alectinib in a Patient With Metastatic ALK-rearranged Lung Adenocarcinoma.

Five-year Disease Control With Alectinib in a Patient With Metastatic ALK-rearranged Lung Adenocarcinoma.

Journal: Cancer diagnosis & prognosis

Published: September 02, 2022

Octogenarians With Anaplastic Lymphoma Kinase-rearranged Non-small-cell Lung Cancer: A Case Series.

Octogenarians With Anaplastic Lymphoma Kinase-rearranged Non-small-cell Lung Cancer: A Case Series.

Journal: Cancer diagnosis & prognosis

Published: August 22, 2022

Discontinuation of Immune Checkpoint Inhibitor and Survival in Patients With Non-small-cell Lung Cancer Without a Driver Gene Mutation.

Discontinuation of Immune Checkpoint Inhibitor and Survival in Patients With Non-small-cell Lung Cancer Without a Driver Gene Mutation.

Journal: Anticancer research

Published: June 02, 2022

Bloody pericardial effusion during chemotherapy with immune checkpoint inhibitors.

Bloody pericardial effusion during chemotherapy with immune checkpoint inhibitors.

Journal: Cancer immunology, immunotherapy : CII

Published: May 16, 2022

Late-onset pulmonary and cardiac toxicities in a patient treated with immune checkpoint inhibitor monotherapy.

Late-onset pulmonary and cardiac toxicities in a patient treated with immune checkpoint inhibitor monotherapy.

Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti

Published: April 23, 2022

Prognostic significance associated with the number of compound mutations in epidermal growth factor receptor-mutated non-small cell lung cancer.

Prognostic significance associated with the number of compound mutations in epidermal growth factor receptor-mutated non-small cell lung cancer.

Journal: Polish archives of internal medicine

Published: April 14, 2022

Body Weight Change in Non-small Cell Lung Cancer Patients Treated With EGFR-TKI.

Body Weight Change in Non-small Cell Lung Cancer Patients Treated With EGFR-TKI.

Journal: Cancer diagnosis & prognosis

Published: February 08, 2022

Significance of Polar Charged Amino Acids in Compound Mutations in EGFR-mutated Patients Treated With First-line Afatinib.

Significance of Polar Charged Amino Acids in Compound Mutations in EGFR-mutated Patients Treated With First-line Afatinib.

Journal: In vivo (Athens, Greece)

Published: February 06, 2022

Difficulty in thoracic catheter insertion in a very obese patient.

Difficulty in thoracic catheter insertion in a very obese patient.

Journal: Tuberkuloz ve toraks

Published: December 27, 2021

Showing 1-12 of 31

Last Updated: 09/26/2026